Get Social With Us

Capacity Counts

By: Thomas C. Ransohoff and Howard L. Levine, Ph.D.
Reprinted with permission of Inside Outsourcing, Pharm Exec, November 2009

BioProcess Technology Consultants and PharmSource Information Services recently published a detailed report analyzing the complex and dynamic balance of supply and demand for mammalian cell culture manufacturing capacity for production of therapeutic recombinant proteins and monoclonal antibodies. This article summarizes the key findings and results from this report and provides commentary on several trends in biopharmaceutical manufacturing, including advances in technology which may lead to significantly lower utilization of existing capacity, globalization of the biopharmaceutical industry, and the emergence of biosimilar products.